Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures

Launched by UNIVERSITY OF MANITOBA · Feb 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a special cream called EMLA, which numbs the skin, when used during certain outpatient surgeries on the scrotum. The goal is to see if applying this cream can help make these procedures, which are typically done with local anesthesia alone, more comfortable for patients. The surgeries being looked at include treatments for conditions like hydrocele and spermatocele, and the researchers want to find out if the cream will help patients tolerate the procedures better.

To participate in this trial, men aged 18 and older who are scheduled for specific scrotal surgeries under local anesthesia are eligible. However, if a patient is going to receive sedation or does not agree to be part of the study, they cannot participate. Those who join can expect to have their comfort levels compared between those using the EMLA cream and those who do not, helping to improve future care for similar surgeries. This trial is currently recruiting participants, so there’s an opportunity to contribute to better understanding patient comfort in these procedures.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Adult patients undergoing hydrocelectomy, spermatocelectomy, epididymectomy, testicular biopsy, scrotal lesion or cyst excision under local anesthesia alone were included.
• Exclusion Criteria:
• • Patients were excluded if their procedure was to be performed with sedatives (e.g., inhaled nitrous oxide gas, oral, or IV sedation) or did not provide consent to be randomized